Covered recipient · General Payments record
SHAIK M UBAID
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,433.54
- Reported across 292 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,277.10 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SK Life Science, Inc. | $284.88 | 5 |
| ARGENX US, INC. | $206.55 | 6 |
| ABBVIE INC. | $147.71 | 11 |
| PFIZER INC. | $132.77 | 7 |
| UCB, Inc. | $119.63 | 6 |
| Lilly USA, LLC | $87.57 | 5 |
| Alexion Pharmaceuticals, Inc. | $56.53 | 2 |
| EISAI INC. | $46.54 | 2 |
| EMD Serono, Inc. | $41.21 | 2 |
| LivaNova USA, Inc. | $35.64 | 2 |
| Neurocrine BioSciences, Inc. | $28.44 | 1 |
| Ardelyx, Inc. | $27.99 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.04 | 1 |
| Ipsen Biopharmaceuticals, Inc | $21.58 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $17.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.92 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257095 | CMS |
| ABBVIE INC. | $3.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257097 | CMS |
| ABBVIE INC. | $33.81 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257099 | CMS |
| ABBVIE INC. | $4.09 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257101 | CMS |
| ABBVIE INC. | $20.63 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257103 | CMS |
| ABBVIE INC. | $21.29 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257105 | CMS |
| ABBVIE INC. | $21.14 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257107 | CMS |
| ABBVIE INC. | $5.40 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257110 | CMS |
| ABBVIE INC. | $4.32 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257112 | CMS |
| ABBVIE INC. | $19.14 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257114 | CMS |
| ABBVIE INC. | $3.98 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106257116 | CMS |
| Alexion Pharmaceuticals, Inc. | $22.68 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093911343 | CMS |
| Alexion Pharmaceuticals, Inc. | $33.85 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094049087 | CMS |
| Ardelyx, Inc. | $27.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712047 | CMS |
| ARGENX US, INC. | $23.38 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106409 | CMS |
| ARGENX US, INC. | $24.78 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112441 | CMS |
| ARGENX US, INC. | $21.69 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142126287 | CMS |
| ARGENX US, INC. | $115.20 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142116413 | CMS |
| ARGENX US, INC. | $17.73 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118341 | CMS |
| ARGENX US, INC. | $3.77 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118343 | CMS |
| Eisai Inc. | $24.94 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110780776 | CMS |
| Eisai Inc. | $21.60 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110780778 | CMS |
| EMD Serono, Inc. | $22.04 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120257758 | CMS |
| EMD Serono, Inc. | $19.17 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120271342 | CMS |
| Ipsen Biopharmaceuticals, Inc | $21.58 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091954005 | CMS |
| Lilly USA, LLC | $15.61 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135386367 | CMS |
| Lilly USA, LLC | $17.28 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135414113 | CMS |
| Lilly USA, LLC | $21.11 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135400359 | CMS |
| Lilly USA, LLC | $18.20 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135421843 | CMS |
| Lilly USA, LLC | $15.37 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135372620 | CMS |
| LivaNova USA, Inc. | $20.70 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152793427 | CMS |
| LivaNova USA, Inc. | $14.94 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152793557 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $17.02 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144509494 | CMS |
| Neurocrine Biosciences, Inc. | $28.44 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150829600 | CMS |
| PFIZER INC. | $17.91 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131808671 | CMS |
| PFIZER INC. | $21.88 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131797982 | CMS |
| PFIZER INC. | $9.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131918657 | CMS |
| PFIZER INC. | $27.80 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131801488 | CMS |
| PFIZER INC. | $21.17 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131966103 | CMS |
| PFIZER INC. | $21.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131983473 | CMS |
| PFIZER INC. | $13.14 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131941699 | CMS |
| SK Life Science, Inc. | $20.79 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127500 | CMS |
| SK Life Science, Inc. | $99.20 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127610 | CMS |
| SK Life Science, Inc. | $23.30 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127580 | CMS |
| SK Life Science, Inc. | $22.96 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127596 | CMS |
| SK Life Science, Inc. | $118.63 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127624 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.04 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137690319 | CMS |
| UCB, Inc. | $21.94 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153160 | CMS |
| UCB, Inc. | $17.19 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153164 | CMS |
| UCB, Inc. | $14.13 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153168 | CMS |
| UCB, Inc. | $16.07 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153172 | CMS |
| UCB, Inc. | $23.05 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153176 | CMS |
| UCB, Inc. | $27.25 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143153180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.